CNNM2

Chr 10ADAR

cyclin and CBS domain divalent metal cation transport mediator 2

Also known as: ACDP2, HOMG6, HOMGSMR, SLC70A2

This gene encodes a member of the ancient conserved domain containing protein family. Members of this protein family contain a cyclin box motif and have structural similarity to the cyclins. The encoded protein may play an important role in magnesium homeostasis by mediating the epithelial transport and renal reabsorption of Mg2+. Mutations in this gene are associated with renal hypomagnesemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]

OMIMResearchGenerating clinical summary…
LOFmechanismAD/ARLOEUF 0.272 OMIM phenotypes
Clinical SummaryCNNM2
🧬
Gene-Disease Validity (ClinGen)
hypomagnesemia, seizures, and intellectual disability 1 · SDDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
44 unique Pathogenic / Likely Pathogenic· 278 VUS of 542 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.27LOEUF
pLI 0.995
Z-score 4.48
OE 0.10 (0.050.27)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
4.41Z-score
OE missense 0.44 (0.400.49)
219 obs / 495.2 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.10 (0.050.27)
00.351.4
Missense OE?0.44 (0.400.49)
00.61.4
Synonymous OE?1.10
01.21.6
LoF obs/exp: 3 / 29.0Missense obs/exp: 219 / 495.2Syn Z: -1.19
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveCNNM2-related neurodevelopmental disorder with hypomagnesemiaLOFAR
strongCNNM2-related neurodevelopmental disorder with hypomagnesemiaOTHERAD

This gene — mechanism propensity

DN
0.4686th %ile
GOF
0.6248th %ile
LOF
0.64top 25%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOF1 literature citation · 43% of P/LP variants are LoF · LOEUF 0.27

Literature Evidence

LOFThe phenotypic and genetic spectrum of patients with heterozygous mutations in cyclin M2 (CNNM2)1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 33600043

ClinVar Variant Classifications

542 submitted variants in ClinVar

Classification Summary

Pathogenic24
Likely Pathogenic20
VUS278
Likely Benign155
Benign41
Conflicting14
24
Pathogenic
20
Likely Pathogenic
278
VUS
155
Likely Benign
41
Benign
14
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
9
13
2
0
24
Likely Pathogenic
10
9
1
0
20
VUS
8
241
21
8
278
Likely Benign
0
5
32
118
155
Benign
0
2
30
9
41
Conflicting
14
Total2727086135532

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

20 pathogenic / likely-pathogenic (of 26) ClinVar copy-number / structural variants overlap CNNM2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CNNM2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →